Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1016/j.vaccine.2007.02.069

Type

Journal article

Journal

VACCINE

Publisher

ELSEVIER SCI LTD

Publication Date

22/05/2007

Volume

25

Pages

4324 - 4333

Addresses

Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30303 USA, Univ London Imperial Coll Sci & Technol, London, England, Merck Res Labs, West Point, PA USA, Sanofi Pasteur MSD, Lyon, France, Univ S Florida, Moffitt Canc Ctr & Res Inst, Tampa, FL USA

Keywords

Science & Technology, Life Sciences & Biomedicine, Immunology, Medicine, Research & Experimental, Research & Experimental Medicine, IMMUNOLOGY, MEDICINE, RESEARCH & EXPERIMENTAL, HPV-16, VLP, prophylactic HPV vaccine, antibody duration, modeling, RANDOMIZED CONTROLLED-TRIAL, HEPATITIS-A VACCINE, YOUNG-WOMEN, FOLLOW-UP, BORDETELLA-PERTUSSIS, SUSTAINED EFFICACY, NATURAL-HISTORY, WANING IMMUNITY, CERVICAL-CANCER, L1